Abstracts

Search by keyword or author name.

Showing 852 abstracts.

Violet Korutaro, Kristin Baltrusaitis, Patricia DeMarrais, Adeodata R Kekitiinwa, Lameck Chinula, Sufia Dadabhai, Maxensia Owor, Mary Glenn Fowler, Patricia Flynn, Louise Kuhn, Kennedy Spann, Lars Bode, Robin Brody, Katherine Luzuriaga, Shahin Lockman, Jennifer Jao, PROMISE study. Maternal Human Milk Immune Profiles Associated with Postnatal HIV Transmission to Infants During Breastfeeding in the PROMISE Study. Presented at: AIDS; 2026 Jul 30; Rio de Janeiro, Brazil.

Conference

AIDS

Study

1077BF

Conference Location

Rio de Janeiro, Brazil
Ashenafi S Cherkos, Sylvia M. LaCourse, Daniel A Enquobahrie, Grace Montepiedra, Caroline Onyango, Blandina T. Mmbaga, Tichaona Vhembo, Gaerolwe Masheto, Gerhard Theron, Adriana Weinberg, Amita Gupta, IMPAACT P1078 TB APPRISE Study team, Barbra A Richardson, Grace John-Stewart. Maternal IPT in pregnancy and growth faltering among HIV-exposed uninfected infants. Presented at: CROI 2022; 2022 Feb 14.

Conference

CROI 2022

Study

P1078
Rhoda S. Sperling, M.D. Maternal Plasma HIV-1 RNA and the Success of Zidovudine (ZDV) in the Prevention of Mother-Child Transmission.
Heather D. Watts, M.D., Rajalaksh Balasubramanian, Sc.D., Robert T. Maupin, Jr., M.D., Issac Delke, M.D., Coleen K. Cunningham, M.D., Alejandro Dorenbaum, M.D., Simone Fiore, M.D., Marie Louise Newell, M.D., Jean-Francois Delfraissy, M.D., Richard D. Gelber, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Mary Culnane, C.R.N.P., M.S., John L. Sullivan, M.D. Maternal Toxicity and Pregnancy Outcome According to Antiretroviral Therapy during Pregnancy. An analysis of the PACTG 316 Study.
A. Tatsoni, Elaine J. Abrams, M.D., Marc Bulterys, M.D., Ph.D., Robert W. Coombs, M.D., Ph.D., James J. Goedert, M.D., Bette T. Korber, M. J. Mayaux, Lynne M. Mofenson, M.D., F.A.A.P., Marie Louise Newell, M.D., Kenneth C. Rich, M.D., David E. Shapiro, Ph.D., J. P. Teglas, Betsy Thompson, J. Weiner, John P.A. Ioannidis, M.D. Maternal viral load and infant disease progression in vertically HIV-1 infected infants: An international meta-analysis. Presented at: 10th Conference on Retroviruses & Opportunistic Infections.

Conference

10th Conference on Retroviruses & Opportunistic Infections
Maturation of glucuronidation; a system specific property.
NH Tobin, A Murphy, F Li, S Brummel, MG Fowler, J McIntyre, JS Currier, T Chipato, P Flynn, B Koos, GM Aldrovandi, PROMISE team. Metabolites, preterm labor and antiretroviral therapy. Presented at: CROI 2020; 2020 Mar 11.

Conference

CROI 2020

Study

1077BF
Methods for Choosing A Cut Point When Dichotomizing A Continuous Response – A Case Study of Predicting Infant Survival with High Resolution Melting Score. Presented at: 89th Int'l Association for Dental Research/40th American Association for Dental Research.

Conference

89th Int'l Association for Dental Research/40th American Association for Dental Research
Methylphenidate Concentrations and Dose Requirements in HIV-infected and Uninfected Children, Adolescents and Young Adults. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Conference

20th Conference on Retroviruses and Opportunistic Infections

Study

P1080
Microarray analysis reveals novel insights into immunity to H1N1/09 influenza vaccine in HIV infected children and adolescents in IMPAACT protocol 1088. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Conference

20th Conference on Retroviruses and Opportunistic Infections

Study

P1088